← Feed

$KPTI

2 theses
bullish 50%neutral 50%bearish 0%
Avg return (3m)
—
Win rate (3m)
— (0 resolved)
1d3d1w1m3m6m1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 9, 9:00 AM ET
$KPTIr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄neutral
u/Avish_Golakiya · 2d ago14 prior · awaiting results

10 penny biotechs I'm watching and slowly adding for September 2026, and the one I got wrong in August.

KPTI trades below its cash balance despite priority review and accelerated approval request, with Q4 FDA filing news ahead. At 54% short float, 7 months of runway, and $41M cap against $65M liquidity, the stock faces dilution risk before any approval catalyst.

At post $1.72Now $1.720.0% since postedas of Sep 9, 9:00 AM ET
original post →
$KPTIr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish
u/Avish_Golakiya · 35d ago14 prior · awaiting results

10 penny biotechs I'm watching for August 2026, and adding slowly

Karyopharm trades below tangible cash value at $2/share with a selinexor sNDA decision (myelofibrosis combo with ruxolitinib) due Aug 31. 35% short float and three quarters of specialist fund accumulation suggest smart money disagrees with the market's 80% July sell-off, though 9-month cash runway poses dilution risk.

Now $1.72as of Sep 9, 9:00 AM ET
original post →

End of results.